Assignee
BEIJING TUO JIE BIOPHARMACEUTICAL CO LTD
CN·0 granted patents·7 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
7 records- 0159US2025312444A1Fusion protein of relaxin or analogue and medical use thereofBEIJING TUO JIE BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0255US2024269227A1Calcium-sensing receptor agonist composition and application thereofBEIJING TUO JIE BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0355US2025206797A1Human insulin analogue, and fusion protein thereof and medical use thereofBEIJING TUO JIE BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0450US2024279298A1Glucagon analog and medical use thereofBEIJING TUO JIE BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0547US2023220111A1Anti-fxi/fxia antibody, antigen-binding fragment thereof, and pharmaceutical use thereofBEIJING TUO JIE BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0647US2023190879A1Dual-agonist compound for both glp-1 and gip receptors and application thereofBEIJING TUO JIE BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0747US2023041996A1Calcium-sensing receptor agonist compound and application thereofBEIJING TUO JIE BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BEIJING TUO JIE BIOPHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →